Ketamine Plus Lithium as a Novel Pharmacotherapeutic Strategy in Treatment-Resistant Depression
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ketamine (Primary) ; Lithium
- Indications Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
- 31 Jul 2018 Biomarkers information updated
- 03 Jul 2013 New trial record
- 01 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.